Acadia Healthcare (NASDAQ:ACHC) Stock Price Crosses Above Two Hundred Day Moving Average – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $19.47 and traded as high as $23.95. Acadia Healthcare shares last traded at $23.31, with a volume of 2,065,975 shares.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Raymond James Financial raised shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research note on Monday, May 4th. UBS Group raised their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research note on Friday, April 17th. KeyCorp reaffirmed an “overweight” rating and issued a $30.00 price objective on shares of Acadia Healthcare in a research note on Wednesday, May 27th. Cantor Fitzgerald raised their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research note on Friday, May 1st. Finally, Guggenheim increased their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a report on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $26.42.

Acadia Healthcare Price Performance

The business’s fifty day moving average is $25.22 and its 200-day moving average is $19.47. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm has a market cap of $2.14 billion, a PE ratio of -1.90, a P/E/G ratio of 7.80 and a beta of 0.73.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million during the quarter, compared to the consensus estimate of $823.51 million. During the same quarter last year, the company posted $0.40 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 1.49 earnings per share for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in the stock. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Acadia Healthcare by 7.8% in the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares in the last quarter. Goldman Sachs Group Inc. increased its stake in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares in the last quarter. Abrams Bison Investments LLC increased its stake in shares of Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock worth $108,449,000 after purchasing an additional 800,000 shares in the last quarter. Finally, UBS Group AG increased its stake in shares of Acadia Healthcare by 8.8% in the third quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock worth $107,377,000 after purchasing an additional 350,484 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.